These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9808963)

  • 21. [Early and late anthracycline-induced cardiotoxicity in childhood: non-invasive evaluation of contractility in 116 patients].
    Agnoletti G; Bonazza A; Pennacchio M; Porta F; Arrighini A
    G Ital Cardiol; 1995 Oct; 25(10):1295-305. PubMed ID: 8682225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does left ventricular diastolic function deteriorate earlier than left ventricular systolic function in anthracycline cardiotoxicity?
    Patel CD; Balakrishnan VB; Kumar L; Naswa N; Malhotra A
    Hell J Nucl Med; 2010; 13(3):233-7. PubMed ID: 21193876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiopulmonary evaluation of exercise tolerance after chest irradiation and anticancer chemotherapy in children and adolescents.
    Pihkala J; Happonen JM; Virtanen K; Sovijärvi A; Siimes MA; Pesonen E; Saarinen UM
    Pediatrics; 1995 May; 95(5):722-6. PubMed ID: 7724311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors.
    De Wolf D; Suys B; Maurus R; Benoit Y; Verhaaren H; Matthijs D; Otten J
    Pediatr Res; 1996 Mar; 39(3):504-12. PubMed ID: 8929873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study.
    Bu'Lock FA; Mott MG; Oakhill A; Martin RP
    Pediatr Cardiol; 1999; 20(4):252-63. PubMed ID: 10368449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood.
    Iarussi D; Galderisi M; Ratti G; Tedesco MA; Indolfi P; Casale F; Di Tullio MT; de Divitiis O; Iacono A
    Clin Cardiol; 2001 Oct; 24(10):663-9. PubMed ID: 11594412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Echocardiography studies for detection of cardiotoxic side effects of anthracycline therapy in childhood].
    Richter R; Grumpelt U; Mittler U; Kluba U
    Monatsschr Kinderheilkd; 1990 Dec; 138(12):823-7. PubMed ID: 1965011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late cardiotoxic effects of anthracycline chemotherapy in childhood malignancies.
    Roodpeyma S; Moussavi F; Kamali Z
    J Pak Med Assoc; 2008 Dec; 58(12):683-7. PubMed ID: 19157322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
    Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
    J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue Doppler and myocardial deformation imaging to detect myocardial dysfunction in pediatric cancer patients treated with high doses of anthracyclines.
    Yağci-Küpeli B; Varan A; Yorgun H; Kaya B; Büyükpamukçu M
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):368-74. PubMed ID: 22898185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anthracyclines and the heart].
    Mazzarello GP; Morra L
    Recenti Prog Med; 1998 Sep; 89(9):459-64. PubMed ID: 9796378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
    Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
    Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
    Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of anthracycline-induced early left ventricular dysfunction in children with cancer: a comparative study with echocardiography and multigated radionuclide angiography.
    Corapçioglu F; Sarper N; Berk F; Sahin T; Zengin E; Demir H
    Pediatr Hematol Oncol; 2006; 23(1):71-80. PubMed ID: 16326416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth-differentiation factor-15 and tissue doppler ımaging in detection of asymptomatic anthracycline cardiomyopathy in childhood cancer survivors.
    Arslan D; Cihan T; Kose D; Vatansev H; Cimen D; Koksal Y; Oran B; Akyurek F
    Clin Biochem; 2013 Sep; 46(13-14):1239-43. PubMed ID: 23850849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines.
    Guimaraes-Filho F; Tan D; Braga J; Rodrigues A; Waib P; Matsubara B
    Am J Cardiol; 2007 Oct; 100(8):1303-6. PubMed ID: 17920375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer.
    Elbl L; Hrstkova H; Chaloupka V
    Eur J Pediatr; 2003 Oct; 162(10):690-6. PubMed ID: 12905011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.
    Bossi G; Lanzarini L; Laudisa ML; Klersy C; Raisaro A; Aricò M
    Med Pediatr Oncol; 2001 Jun; 36(6):593-600. PubMed ID: 11344489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer.
    Hamada H; Ohkubo T; Maeda M; Ogawa S
    Pediatr Int; 2006 Jun; 48(3):313-20. PubMed ID: 16732801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.
    Andolina JR; Dilley K
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.